论文部分内容阅读
Ｈｏｆｆｍａｎ－Ｌａ Ｒｏｃｈｅ公司就其减肥药奥利司他（ｏｒｌｉ－ｓｔａｔ，Ｘｅｎｉｃａｌ）向美国ＦＤＡ提出一项增补申请，即用于Ⅱ型糖尿病的辅助治疗。 本品于１９９９年４月获得美国许可用于肥胖症治疗，包括减轻体重和维持治疗。ＦＤＡ还批准本品用于减少体重反弹
Hoffman-La Roche proposed a supplement to the US FDA for its diet pill orli-stat (Xenical) for adjuvant treatment of type 2 diabetes. This product was approved by the United States in April 1999 for the treatment of obesity, including weight loss and maintenance treatment. FDA also approved this product for reducing body weight rebound